Related references
Note: Only part of the references are listed.Cytokine serum levels remain unchanged during lithium augmentation of antidepressants in major depression
Roland Ricken et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression
Andre R. Brunoni et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Changes in the tryptophan-kynurenine axis in association to therapeutic response in clinically depressed patients undergoing psychiatric rehabilitation
B. Reininghaus et al.
PSYCHONEUROENDOCRINOLOGY (2018)
Differences in immunomodulatory properties between venlafaxine and paroxetine in patients with major depressive disorder
Chun-Yen Chen et al.
PSYCHONEUROENDOCRINOLOGY (2018)
The Phosphodiesterase Inhibitor Pentoxifylline as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
Sahar Mohamed El-Haggar et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2018)
Effect of Agomelatine and Fluoxetine on HAM-D Score, Serum Brain-Derived Neurotrophic Factor, and Tumor Necrosis Factor- Level in Patients With Major Depressive Disorder With Severe Depression
Keshav Gupta et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Higher Baseline Proinflammatory Cytokines Mark Poor Antidepressant Response in Bipolar Disorder
Francesco Benedetti et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Proteomics profiling reveals inflammatory biomarkers of antidepressant treatment response: Findings from the CO-MED trial
Bharathi S. Gadad et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Biological profiling of prospective antidepressant response in major depressive disorder: Associations with (neuro)inflammation, fatty acid metabolism, and amygdala-reactivity
R. J. T. Mocking et al.
PSYCHONEUROENDOCRINOLOGY (2017)
Oxidative stress, inflammation and treatment response in major depression
Daniel Lindqvist et al.
PSYCHONEUROENDOCRINOLOGY (2017)
Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor
Kyoko Hasebe et al.
ACTA NEUROPSYCHIATRICA (2017)
Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies
C. A. Kohler et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Increased plasma levels of competing amino acids, rather than lowered plasma tryptophan levels, are associated with a non-response to treatment in major depression
Heidi Ormstad et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Evaluation of interleukin-6 and serotonin as biomarkers to predict response to fluoxetine
Aarthi Manoharan et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2016)
Effect of Fluoxetine on Inflammatory Cytokines in Drug-Naive Major Depression A Short-Term Prospective Study from South India
Avin Muthuramalingam et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Effect of Mirtazapine Treatment on Serum Levels of Brain-Derived Neurotrophic Factor and Tumor Necrosis Factor-α in Patients of Major Depressive Disorder with Severe Depression
Rachna Gupta et al.
PHARMACOLOGY (2016)
Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
Woojae Myung et al.
PSYCHIATRY INVESTIGATION (2016)
Pro- and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression
Frank M. Schmidt et al.
PSYCHIATRY RESEARCH (2016)
Inflammation and clinical response to treatment in depression: A meta-analysis
R. Strawbridge et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline
Rudolf Uher et al.
AMERICAN JOURNAL OF PSYCHIATRY (2014)
Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial
Andre R. Brunoni et al.
PSYCHOPHARMACOLOGY (2014)
The Epidemiology of Depression Across Cultures
Ronald C. Kessler et al.
ANNUAL REVIEW OF PUBLIC HEALTH, VOL 34 (2013)
Effect of Selective Serotonin Reuptake Inhibitors and Immunomodulator on Cytokines Levels: An Alternative Therapy for Patients with Major Depressive Disorder
Maria Eugenia Hernandez et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder
Reiji Yoshimura et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2013)
Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds
Michele Fornaro et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-α) in the Chinese patients with major depressive disorder: A prospective longitudinal study
Zezhi Li et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Treatment response and cognitive impairment in major depression: Association with C-reactive protein
Hui Hua Chang et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia
Ross J. Tynan et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity
Sarah A. Hiles et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
Investigation of circulating endothelial progenitor cells and angiogenic and inflammatory cytokines during recovery from an episode of major depression
Peter Dome et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
Jonas Hannestad et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation
Michele Fornaro et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2011)
Genome-Wide Pharmacogenetics of Antidepressant Response in the GENDEP Project
Rudolf Uher et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
A Meta-Analysis of Cytokines in Major Depression
Yekta Dowlati et al.
BIOLOGICAL PSYCHIATRY (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Elevated C-reactive protein in depression: a predictor of good long-term outcome with antidepressants and poor outcome with psychotherapy
J. Harley et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Conducting Meta-Analyses in R with the metafor Package
Wolfgang Viechtbauer
JOURNAL OF STATISTICAL SOFTWARE (2010)
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Andrew H. Miller et al.
BIOLOGICAL PSYCHIATRY (2009)
Effects of bupropion augmentation on pro-inflammatory cytokines in escitalopram-resistant patients with major depressive disorder
T. Eller et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression
Reiji Yoshimura et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Pro-inflammatory biomakers in depression: Treatment with venlafaxine
John E. Piletz et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2009)
Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors
Mia Levite
CURRENT OPINION IN PHARMACOLOGY (2008)
Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder
Maria Eugenia Hernandez et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder
Triin Eller et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Meta-analysis of skewed data: Combining results reported on log-transformed or raw scales
Julian P. T. Higgins et al.
STATISTICS IN MEDICINE (2008)
Cytokine profiles in women with different subtypes of major depressive disorder
A. H. Marques-Deak et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2007)
Successful antidepressant therapy restores the disturbed interplay between TNF-α system and HPA axis
Hubertus Himmerich et al.
BIOLOGICAL PSYCHIATRY (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Cytokines sing the blues: inflammation and the pathogenesis of depression
CL Raison et al.
TRENDS IN IMMUNOLOGY (2006)
IL-6 levels decrease with SSRI treatment in patients with major depression
AD Basterzi et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2005)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder
C Tuglu et al.
PSYCHOPHARMACOLOGY (2003)
Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis
O Mikova et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2001)
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
S Duval et al.
BIOMETRICS (2000)
Cytokines and the brain: Implications for clinical psychiatry
Z Kronfol et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Cytokine production and treatment response in major depressive disorder
S Lanquillon et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Share Paper
